Skip to main content
. 2017 Apr 17;8(23):37740–37750. doi: 10.18632/oncotarget.17147

Figure 1. Schematic strategy for the identification of useful epigenetic biomarkers for the prediction of the presence of LNM in primary ESCC cases.

Figure 1